Andrew Kalusa

NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis

Suzanne A. Eccles, Andy Massey, Florence I. Raynaud et al. · Cancer Research · 2008 · 478 citations · Full text

Medicine, Oncology, Pharmacology +8

Inhibition of the heat shock protein 90 molecular chaperone <i>in vitro</i> and <i>in vivo</i> by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues

Swee Y. Sharp, Chrisostomos Prodromou, Kathy Boxall et al. · Molecular Cancer Therapeutics · 2007 · 143 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Sebastian Trousil, Maciej Kaliszczak, Zachary T. Schug et al. · Oncotarget · 2016 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

An efficient synthesis of 2,3-diaryl (3H)-quinazolin-4-ones via imidoyl chlorides

Andrew Kalusa, N. Chessum, Keith Jones · Tetrahedron Letters · 2008 · 32 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

Detection of the ATPase Activity of the Molecular Chaperones Hsp90 and Hsp72 Using the Transcreener™ ADP Assay Kit

Martin Rowlands, Craig McAndrew, Chrisostomos Prodromou et al. · SLAS DISCOVERY · 2010 · 32 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17